Literature DB >> 7562271

Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease.

P J Chesney1, J A Wilimas, G Presbury, S Abbasi, R J Leggiadro, Y Davis, S W Day, G E Schutze, W C Wang.   

Abstract

OBJECTIVE: We investigated the possibility that antimicrobial-resistant pneumococci were causing invasive disease in children with sickle-cell disease (SCD). STUDY
DESIGN: Records of all children with SCD observed at the Mid-South Sickle Cell Center (MSSCC) at LeBonheur Children's Medical Center were reviewed from January 1990 to June 1994. Children with SCD and pneumococcal sepsis were identified. The Streptococcus pneumoniae isolates from these children were examined for serotype and antimicrobial susceptibilities. Two additional children not observed in the MSSCC had pneumococcal sepsis caused by penicillin-resistant isolates and were also included.
RESULTS: Antimicrobial susceptibility testing of the six penicillin-resistant isolates revealed that four were resistant to trimethoprim-sulfamethoxazole, two to erythromycin, and one to clindamycin. The two isolates that were resistant to ceftriaxone also were multiply resistant. From the MSSCC, 26 children had pneumococcal sepsis during the 4 1/2-year period studied. Five of these children (19%) died. Four (15%), including one who died, were infected with penicillin-resistant strains.
CONCLUSION: Pneumococcal sepsis, meningitis, and infections of other foci in children with SCD may be caused by S. pneumoniae that is resistant to one or more antimicrobial agents, including penicillin. The addition of vancomycin to the antibiotics currently used for initial management should be considered in areas where the antibiotic resistance of S. pneumoniae is prevalent.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562271     DOI: 10.1016/s0022-3476(95)70107-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

Review 1.  Drug-resistant pneumococcal pneumonia: clinical relevance and approach to management.

Authors:  J D Fuller; A McGeer; D E Low
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Penicillin prophylaxis in children with sickle cell disease.

Authors:  Mary Petrea Cober; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2010-07

3.  Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995.

Authors:  R Heffernan; K Henning; A Labowitz; A Hjelte; M Layton
Journal:  Emerg Infect Dis       Date:  1998 Jan-Mar       Impact factor: 6.883

4.  Extremely high prevalence of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae among children in Kaohsiung, Taiwan.

Authors:  C C Chiou; Y C Liu; T S Huang; W K Hwang; J H Wang; H H Lin; M Y Yen; K S Hsieh
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

Review 5.  Management of infections due to antibiotic-resistant Streptococcus pneumoniae.

Authors:  S L Kaplan; E O Mason
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.